Pediatric Pneumonia Treatment
The recommended first-line treatment for pediatric community-acquired pneumonia is high-dose oral amoxicillin at 90 mg/kg/day divided into two doses (maximum 4 g/day) for children under 5 years. 1
Treatment Algorithm by Age and Severity
Outpatient Management (Mild-Moderate Pneumonia)
First-line therapy:
Alternative options (for penicillin allergy):
Suspected Atypical Pneumonia
- First-line for Mycoplasma pneumonia:
Inpatient Management (Severe Pneumonia)
Fully immunized children:
- Ampicillin or penicillin G 1
Not fully immunized or high local resistance:
Dosing Considerations
Amoxicillin Dosing
- Standard dosing: 45-50 mg/kg/day divided into 3 doses
- High-dose therapy: 90 mg/kg/day divided into 2 doses (recommended for pneumonia) 1, 5
- Maximum daily dose: 4 g/day 1
Azithromycin Dosing for Pneumonia
- Children ≥6 months: 10 mg/kg (max 500 mg) on day 1, followed by 5 mg/kg (max 250 mg) on days 2-5 1, 4
Treatment Duration
- Uncomplicated pneumonia: 5 days of therapy is as effective as longer courses (7-10 days) 1, 2, 3
- Severe pneumonia: Continue treatment for at least 48-72 hours beyond symptom resolution 1
Monitoring Response
- Assess for clinical improvement within 48-72 hours of starting antibiotics 1
- Signs of improvement include:
- Decreased fever
- Improved respiratory rate
- Decreased work of breathing 1
Hospitalization Criteria
Consider hospital admission for children with:
- Severe respiratory distress
- Oxygen saturation <92% or cyanosis
- Inability to maintain oral hydration
- Toxic appearance
- Failure to respond to outpatient management
- Respiratory rate >50 breaths/min in infants
- All infants ≤8 weeks with pneumonia 1
Common Pitfalls to Avoid
- Inadequate dosing: Using standard adult doses rather than weight-based dosing can lead to treatment failure 1
- Excessive treatment duration: Defaulting to 10-day courses regardless of clinical response may contribute to antimicrobial resistance 1
- Delayed reassessment: Not evaluating response after 48-72 hours can delay necessary changes in treatment 1
- Inappropriate use of macrolides: Using macrolides as first-line therapy in young infants with typical pneumonia 1
- Ignoring local resistance patterns: Not considering local antibiotic resistance when selecting empiric therapy 1
Evidence Quality and Considerations
Recent evidence from randomized controlled trials supports shorter courses (5 days) of amoxicillin for uncomplicated pneumonia 2, 3, 6. A multicentre equivalency study also found that oral amoxicillin is as effective as injectable penicillin for severe pneumonia in children aged 3-59 months 7, which has important implications for treatment in resource-limited settings.
The American Academy of Pediatrics and the Infectious Diseases Society of America emphasize antibiotic stewardship by recommending narrow-spectrum antibiotics when effective and avoiding unnecessary broad-spectrum antibiotics 1.